Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04752163
Title DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center
Indications

acute lymphoblastic leukemia

acute myeloid leukemia

Therapies

Cyclophosphamide + Cytarabine + Dexamethasone + DS-1594b + Filgrastim + Mesna + Methotrexate + Vincristine Sulfate

DS-1594b + Prednisone + Vincristine Sulfate

DS-1594b

Azacitidine + DS-1594b + Venetoclax

Cytarabine + DS-1594b + Filgrastim + Leucovorin + Methotrexate

Cytarabine + DS-1594b + Filgrastim + Leucovorin + Methotrexate + Rituximab

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST